UAE: Chinese vaccine links point to complex relationships

Issue 1107 - 17 Jul 2020 | 1 minute read

Among the growing number of UAE-China links is the search for a cure for Covid-19. UAE government-associated company Group42 in June announced it was launching a phase three clinical trial for a vaccine in partnership with the giant Sinopharm China National Biotec Group. In a joint statement the companies said they aimed to have a vaccine ready for use “by the end of 2020 or early 2021.”

Want to read more?

Subscribe to Gulf States Newsletter

View subscription options

Don't have an account?

Register for access to our free content

An account also allows you to view selected free articles and set up news alerts.


Join our community

Sign up for an account to gain:

  • Set up news alerts on the countries and sectors that matter to you.
  • Free access to newsletter articles under 100 words.
  • Free access to GSN View articles articles.

View a selection of Free articles

Explore subscription options

Follow us on Google News